Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat

Synapse
N RajakumarA J Stoessl

Abstract

An antisense oligonucleotide strategy was employed to specifically deplete postsynaptic striatal D2 receptors in order to determine the possible role of presynaptic D2 autoreceptors in mediating behavioral responses induced by low doses of apomorphine. A phosphorothioate-modified antisense oligonucleotide complementary to the first 19 bases of the coding region of D2 receptor mRNA, a scrambled sequence comprising the same bases, or saline was infused bilaterally into the striatum of adult rats, twice daily for 2 days via indwelling cannulae. After an interval of 8-12 h, rats were habituated and challenged with high (300 micrograms/kg; subcutaneous) or low (50 micrograms/kg; s.c.) doses of apomorphine or its vehicle (0.1% ascorbic acid). Yawning, vacuous chewing mouth movements, hypoexploration, and penile grooming induced by low-dose apomorphine were unaffected by antisense infusion into the striatum, whereas stereotypic sniffing following high-dose apomorphine was markedly suppressed. Intrastriatal infusion of antisense resulted in significantly diminished [3H]-raclopride binding, while binding of [3H]-SCH 23390 (D1 receptors) and [3H]-WIN 35428 (dopamine transporter) was unchanged. D2 mRNA levels determined by quantitative in...Continue Reading

References

Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Walters, R H Roth
Feb 25, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·U Strömbom
Mar 16, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·T C WestfallJ Glowinski
Mar 14, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·G K Aghajanian, B S Bunney
Oct 1, 1977·Pharmacology, Biochemistry, and Behavior·E Mogilnicka, V Klimek
Jan 11, 1979·Nature·J W Kebabian, D B Calne
Feb 11, 1992·Trends in Pharmacological Sciences·D R Sibley, F J Monsma
Aug 14, 1991·European Journal of Pharmacology·O CivelliH H Van Tol
Jan 1, 1991·Progress in Neuro-psychopharmacology & Biological Psychiatry·M R Lynch
Jan 1, 1990·Neuropsychobiology·P O AllardJ O Marcusson
Jun 1, 1990·Trends in Pharmacological Sciences·P H AndersenM G Caron
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J H Meador-WoodruffO Civelli
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S L LokeL M Neckers
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R Y Walder, J A Walder
Nov 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·K SvenssonA Carlsson
Dec 22, 1988·Nature·J R BunzowO Civelli
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 21, 1986·European Journal of Pharmacology·G SerraG L Gessa
Sep 1, 1972·The Journal of Pharmacy and Pharmacology·W KehrC Atack
Jan 13, 1984·European Journal of Pharmacology·T Zetterström, U Ungerstedt
Aug 3, 1984·European Journal of Pharmacology·A J GowerC L Broekkamp
Jul 1, 1993·Trends in Pharmacological Sciences·D Hoyer, H W Boddeke
Jan 1, 1993·Annual Review of Neuroscience·J A Gingrich, M G Caron
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·L WhitesellL M Neckers

❮ Previous
Next ❯

Citations

Oct 2, 2003·European Journal of Pharmacology·Robert E McCullumsmithJames H Meador-Woodruff
Feb 5, 2000·European Journal of Pharmacology·P SalmiC Wahlestedt
Sep 6, 2000·Pharmacology, Biochemistry, and Behavior·P J MclaughlinJ Brener
May 10, 2003·Brain Research. Brain Research Reviews·Dirk Van OekelenJosée E Leysen
Jan 6, 1999·The European Journal of Neuroscience·M P MartresB Giros
Apr 7, 1999·Antisense & Nucleic Acid Drug Development·A W Szklarczyk, L Kaczmarek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.